Successful Value Retention with Effective Loss of Exclusivity (LoE) Management
One critical aspect goes overlooked is the management of Loss of Exclusivity (LoE)
Loss of exclusivity (LoE) represents a pivotal point in a product’s lifecycle when market exclusivity ends, opening the door to generic competition.
LoE, if not correctly proactively planned, can result in increased competition, which leads to a significant reduction in the price, resulting in revenue erosion and market share loss.
To counteract this, companies must proactively plan their Commercial & Pricing Strategy, as well as develop organizational readiness by establishing LoE-specific and robust capabilities, tools & governance.
Tailoring strategies to individual company needs and their respective asset/product facing LoE, ensures a comprehensive and effective response to the dynamic nature of this phase.
Marbls supports pharmaceutical companies transitioning to LoE with a proven LoE Framework, covering a spectrum of critical stages, including analysis, strategy development, implementation, and ongoing execution.
LoE Service Offerings
Price Impact Assessment
Price Impact Assessment
Organization Planning — Change Management
Organization Planning — Change Management
Program Management and Business Service
Program Management and Business Service
Commercial Planning
Commercial Planning
Technology and Data Services
Technology and Data Services
Learn more in our Thought Leadership:
Successful Value Retention with Effective Loss of Exclusivity (LoE) Management
LoE App
Your app for post-Loss of Exclusivity (LoE) regulatory insights in pharmaceuticals:
• Regulatory anticipation
• Comprehensive insights
• Strategic decision making
